Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Ferring Pharmaceuticals Inc. v. Braintree Laboratories, Inc.
Case Number:
1:13-cv-12553
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
December 14, 2016
Judge OKs Jury Trial In Ferring False Ad Row Over Drug
Braintree Laboratories lost its bid to keep false advertising claims brought by Ferring Pharmaceuticals over a colonoscopy preparation drug from being heard by a jury, after a Massachusetts federal judge determined Tuesday that Ferring is entitled to trial on its "accounting of profits" damage theory — for now.
-
December 05, 2016
New Atty's Scheduling Mixup Not Court's Problem, Judge Says
A Massachusetts federal judge on Monday rejected Ferring Pharmaceuticals' bid to delay a false advertising trial brought by Braintree Laboratories Inc. over Ferring's colonoscopy preparation drug, saying that its new trial counsel should have warned the company about his scheduling conflicts before accepting the case.
-
November 30, 2016
Braintree Labs Fights Ferring False Ad Trial Delay
Braintree Laboratories Inc. on Wednesday urged a federal judge in Massachusetts not to delay a trial against Ferring Pharmaceuticals over alleged false ads about a Ferring colonoscopy bowel preparation drug, saying that the pharmaceutical company's last-minute trial counsel switch was not a good enough reason to put off the January showdown in Massachusetts federal court.
-
October 26, 2016
Bowel Drug False Ad Suit Kept Alive
Two pharmaceutical companies are still locked in a false advertising and trademark feud over a colonoscopy bowel preparation drug, after a Massachusetts federal judge said Tuesday that there were still factual questions about whether one company's use of a newsletter article was misleading.